Skip to main content

Market Overview

19 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 41.9% to $0.59 during Tuesday's pre-market session. The market cap stands at $31.0 million.
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares moved upwards by 19.9% to $0.92. The market cap stands at $10.4 million.
  • Immunogen, Inc. (NASDAQ: IMGN) stock moved upwards by 15.7% to $4.50. The market cap seems to be at $356.2 million.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) stock increased by 11.3% to $0.25. The market value of their outstanding shares is at $20.3 million.
  • Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares surged 10.8% to $7.18. The market cap stands at $180.0 million. The most recent rating by Needham, on October 21, is at Buy, with a price target of $18.00.
  • Synlogic, Inc. (NASDAQ: SYBX) stock increased by 6.7% to $2.40. The market cap seems to be at $69.1 million.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) stock surged 6.5% to $0.33. The market cap seems to be at $4.3 million.
  • Ocugen, Inc. (NASDAQ: OCGN) shares rose 6.3% to $0.42. The market cap stands at $19.7 million. The most recent rating by Chardan Capital, on November 27, is at Buy, with a price target of $2.00.
  • Acer Therapeutics, Inc. (NASDAQ: ACER) shares rose 4.8% to $3.92. The market cap seems to be at $31.5 million.
  • Avadel Pharmaceuticals, Inc. (NASDAQ: AVDL) shares moved upwards by 3.7% to $7.00. The market cap stands at $168.1 million. The most recent rating by Laidlaw & Co., on September 24, is at Buy, with a price target of $6.00.
  • SCYNEXIS, Inc. (NASDAQ: SCYX) shares surged 2.2% to $0.74. The market value of their outstanding shares is at $67.1 million.
  • Genmab, Inc. (NASDAQ: GMAB) shares rose 1.4% to $22.27. The market cap stands at $14.1 billion. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
  • Pfizer, Inc. (NYSE: PFE) shares rose 1.0% to $39.57. The market value of their outstanding shares is at $212.2 billion. The most recent rating by Bank of America, on October 17, is at Neutral, with a price target of $37.00.

 

Losers

  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) shares plummeted 23.7% to $3.32 during Tuesday's pre-market session. The market cap seems to be at $42.4 million.
  • MEI Pharma, Inc. (NASDAQ: MEIP) shares plummeted 23.1% to $1.76. The market cap stands at $133.3 million.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) stock decreased by 9.2% to $11.00. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
  • Aptose Biosciences, Inc. (NASDAQ: APTO) shares fell 1.8% to $4.35. The market value of their outstanding shares is at $113.9 million.
  • MorphoSys, Inc. (NASDAQ: MOR) shares fell 1.6% to $35.72. The market cap stands at $3.4 billion. According to the most recent rating by Guggenheim, on November 20, the current rating is at Buy.
  • Amarin Corp, Inc. (NASDAQ: AMRN) shares fell 1.2% to $22.61. The market cap seems to be at $5.8 billion. The most recent rating by Stifel, on December 16, is at Hold, with a price target of $26.00.
 

Related Articles (ACHV + ACER)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com